Refusion Groupsp. z o.o.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2022-06-09
Share capital
5,000.00 PLN
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $176 |
Filing timeliness
3 of 4 financial statements were filed late (the longest delay 72 days for 2022).
- 202522/08/2026
- 202414/07/2025
- 202305/08/2024
- 202225/09/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Industry · Other research and experimental development on natural sciences and engineering959 / 1,565
Top 61%
Results vs industry
Revenue
This companyUSD 34.47kMedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD 1.63kMedianUSD 69.70AverageUSD 82.18k
Operating costs
This companyUSD 32.51kMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 64.91kMedianUSD 119.88kAverageUSD 3.90m
Industry
Authorized Representatives
Michał Stanisław Kowalczyk – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-11-01.
11 1020 4900 0000 8702 3464 4956
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 27, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Excento sp. z o.o. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Instytut Rybactwa Śródlądowego Im. Stanisława Sakowicza - Państwowy Instytut BadawczyResearch institute | $14,366,048.38 | infish.com.pl | ||
| Etyka Ośrodek Badań Klinicznych Tomasz PestaS.K.A. | $514,414.85 | etykaosrodek.pl | ||
| Uhura Bionicssp. z o.o. | $88,274.48 | uhura.pl | ||
| ATER Netsp. z o.o. | $58,127.56 | aternet.pl | ||
| 4ATsp. z o.o. | $35,272.91 | 4at.pl | ||
| .Protsp. z o.o. | $34,756.89 | dotprot.com | ||
| Basic Solutionsp. z o.o. | $31,812.74 | basicsolution.eu | ||
| Akademia Integracji Medycznejsp. z o.o. | $13.42 | aim-medica.pl | ||
| Kimika Laboratoriessp. z o.o. | $0.00 | kimika.pl | ||
| Upthermo Orcsp. z o.o. | $0.00 | upthermo.com |
FAQ
The main business activity of Refusion Group focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on June 9, 2022.
The headquarters is located at: Pl. Jana Pawła Ii 15, 11-040 Dobre Miasto.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 34,471, representing an increase of 528.2% compared to 2024.
Yes, the company recorded a net profit of USD 1,625 in 2025, meaning the company decreased its profit by 62.9%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 17,662 in 2025, representing 54% of all operating expenses.
Last updated: 2026-08-22